University of Kiel
Also known as: ALL BFM study center Kiel, Germany | Christian-Albrechts-Universität zu Kiel, Klinik für Innere Medizin III Kardiologie, Angiologie und internistische Intensivmedizin, Kiel, Germany | Clinical Research Center Kiel | Clinical Research Center Kiel GmbH | Clinical Research Center Kiel GmbH, Germany | Coordinator Pathology (Germany) Department of Pathology Kiel | CRC Clinical Research Center Kiel | CRC Clinical Research Center, Kiel | Dept. of Dermatology, University of Kiel | Dept. of Dermatology, University of Kiel, Schittenhelmstrasse 5, D-24105 Kiel, Germany | Head of Unit of Neuropathic Pain Research and Therapy, Department of Neurology, University Clinic Kiel | Insitute of Human Nutrition, University of Kiel | Institute of Human Nutrition, Kiel University | Kiel Neurological Pain Centre | Klinik fur Dermatologie, Venerologie und Allerologie - Kiel - Germany | Medical Center II, University of Kiel, Germany | University Hospital Schleswig-Holstein - Campus Lübeck; Department of Gynecology & Obstetrics | University Hospital Schleswig-Holstein, Kiel | University of Kiel | University of Kiel, Arbeitsbereich Sportmedizin und Trainingswissenschaften
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2001Last known activity
Nov 30, 2024
Timeline
1660s
- Jun 1, 1665
University of Kiel— Founded
Drugs by trial phase (51 distinct, 25 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Arterial Occlusive Diseases
- Carcinoma, Hepatocellular
- Common Cold
- Communicable Diseases
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Fibromyalgia
- Glioblastoma
- Hemorrhage
- Hepatoblastoma
- Infections
- Leukemia
- Leukemia, Lymphoid
- Melanoma
- Myofascial Pain Syndromes
- Neoplasm Metastasis
- Neuralgia
- Pancreatic Neoplasms
- Peripheral Arterial Disease
- Peripheral Nervous System Diseases
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Respiratory Tract Infections
- Somatoform Disorders
- Syndrome
- Thyroid Diseases
- Thyroid Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (35)
- NCT06137378CollaboratorPhase 2Nov 30, 2024
- NCT06527677CollaboratorPhase 1Jul 19, 2024
- NCT05126342Overall official - principal investigatorPhase 2May 1, 2022
- NCT04556461Sponsor investigatorPhase 2Sep 28, 2020
- NCT04490226Overall official - principal investigatorN/AAug 21, 2020
- NCT04490226Reponsible party - principal investigatorN/AAug 21, 2020
- NCT04490226Lead sponsorN/AAug 21, 2020
- NCT04754464CollaboratorN/AMay 13, 2020
- NCT04754464Overall official - principal investigatorN/AMay 13, 2020
- NCT04316390Lead sponsorN/AApr 30, 2020
- NCT04316390Reponsible party - principal investigatorN/AApr 30, 2020
- NCT04316390Overall official - principal investigatorN/AApr 30, 2020
- NCT03339973Overall official - principal investigatorPhase 1/Phase 2Mar 5, 2018
- NCT03017326CollaboratorPhase 3May 1, 2017
- NCT02746198Lead sponsorN/AJan 22, 2016
Details
- Founded
- Kiel, DE Jun 1, 1665
- Last known activity
- Nov 30, 2024